Tapewire

Nasdaq · USD

COLL

COLLEGIUM PHARMACEUTICAL, INC

Export transactions ↓
Tapewire entity
5169
SEC CIK
0001267565
Parsed reports
359

Last 12 months

Inside the activity.

0 purchase rows · 14 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202503
Dec 202503
Jan 202600
Feb 202600
Mar 202604
Apr 202600
May 202604
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 13, 2023 Filed Feb 14, 2023 22:16 UTC
Ciaffoni JosephDirector · President and CEO
SaleCommon Stock 11,250 $26.88 $302,400.00
Disclosure

SEC source: 0001062993-23-003475 · form4.xml · nonDerivative · entry 6

Ciaffoni Joseph · CIK 0001443841 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 400,087

F5 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 25, 2022.

F6 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.485 to $27.08, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (6).

Read SEC document
February 13, 2023 Filed Feb 14, 2023 22:16 UTC
Ciaffoni JosephDirector · President and CEO
Exercise / conversionCommon Stock 11,250 $15.90 $178,875.00
Disclosure

SEC source: 0001062993-23-003475 · form4.xml · nonDerivative · entry 5

Ciaffoni Joseph · CIK 0001443841 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 411,337

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 10, 2023 Filed Feb 14, 2023 17:17 UTC
Tupper ColleenEVP & Chief Financial Officer
Tax withholdingCommon Stock 3,887 $26.75 $103,977.25
Disclosure

SEC source: 0001062993-23-003477 · form4.xml · nonDerivative · entry 4

Tupper Colleen · CIK 0001862082 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 137,060

F4 · shares: Shares withheld by the issuer to satisfy applicable withholding taxes upon vesting of performance stock units.

Read SEC document
February 10, 2023 Filed Feb 14, 2023 17:17 UTC
Tupper ColleenEVP & Chief Financial Officer
Tax withholdingCommon Stock 6,967 $26.75 $186,367.25
Disclosure

SEC source: 0001062993-23-003477 · form4.xml · nonDerivative · entry 3

Tupper Colleen · CIK 0001862082 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 140,947

F3 · shares: Shares withheld by the issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.

Read SEC document
February 10, 2023 Filed Feb 14, 2023 17:17 UTC
Tupper ColleenEVP & Chief Financial Officer
GrantCommon Stock 12,565 Not disclosed Not disclosed
Disclosure

SEC source: 0001062993-23-003477 · form4.xml · nonDerivative · entry 2

Tupper Colleen · CIK 0001862082 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 147,914

F2 · price: Effective February 10, 2023, the Compensation Committee of the Board of Directors of the issuer determined that performance-vesting criteria were met with regard to an aggregate of 12,565 performance share units granted in the issuer's three prior fiscal years.

Read SEC document
February 10, 2023 Filed Feb 14, 2023 17:17 UTC
Tupper ColleenEVP & Chief Financial Officer
GrantCommon Stock 45,045 $0.00 $0.00
Disclosure

SEC source: 0001062993-23-003477 · form4.xml · nonDerivative · entry 1

Tupper Colleen · CIK 0001862082 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 135,349

F1 · shares: Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2024, and the balance of the restricted stock units vest in equal annual installments over the following three-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock.

Read SEC document
February 10, 2023 Filed Feb 14, 2023 17:18 UTC
Kuhlmann Shirley R.EVP and General Counsel
Tax withholdingCommon Stock 7,755 $26.75 $207,446.25
Disclosure

SEC source: 0001062993-23-003479 · form4.xml · nonDerivative · entry 4

Kuhlmann Shirley R. · CIK 0001734919 · EVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 159,313

F4 · shares: Shares withheld by the issuer to satisfy applicable withholding taxes upon vesting of performance stock units.

Read SEC document
February 10, 2023 Filed Feb 14, 2023 17:18 UTC
Kuhlmann Shirley R.EVP and General Counsel
Tax withholdingCommon Stock 16,291 $26.75 $435,784.25
Disclosure

SEC source: 0001062993-23-003479 · form4.xml · nonDerivative · entry 3

Kuhlmann Shirley R. · CIK 0001734919 · EVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 167,068

F3 · shares: Shares withheld by the issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.

Read SEC document
February 10, 2023 Filed Feb 14, 2023 17:18 UTC
Kuhlmann Shirley R.EVP and General Counsel
GrantCommon Stock 25,739 Not disclosed Not disclosed
Disclosure

SEC source: 0001062993-23-003479 · form4.xml · nonDerivative · entry 2

Kuhlmann Shirley R. · CIK 0001734919 · EVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 183,359

F2 · price: Effective February 10, 2023, the Compensation Committee of the Board of Directors of the issuer determined that performance-vesting criteria were met with regard to an aggregate of 25,739 performance share units granted in the issuer's three prior fiscal years.

Read SEC document
February 10, 2023 Filed Feb 14, 2023 17:18 UTC
Kuhlmann Shirley R.EVP and General Counsel
GrantCommon Stock 48,125 $0.00 $0.00
Disclosure

SEC source: 0001062993-23-003479 · form4.xml · nonDerivative · entry 1

Kuhlmann Shirley R. · CIK 0001734919 · EVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 157,620

F1 · shares: Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2024, and the balance of the restricted stock units vest in equal annual installments over the following three-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock.

Read SEC document
February 10, 2023 Filed Feb 14, 2023 22:16 UTC
Ciaffoni JosephDirector · President and CEO
Tax withholdingCommon Stock 59,736 $26.75 $1,597,938.00
Disclosure

SEC source: 0001062993-23-003475 · form4.xml · nonDerivative · entry 4

Ciaffoni Joseph · CIK 0001443841 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 400,087

F4 · shares: Shares withheld by the issuer to satisfy applicable withholding taxes upon vesting of performance stock units.

Read SEC document
February 10, 2023 Filed Feb 14, 2023 22:16 UTC
Ciaffoni JosephDirector · President and CEO
Tax withholdingCommon Stock 44,121 $26.75 $1,180,236.75
Disclosure

SEC source: 0001062993-23-003475 · form4.xml · nonDerivative · entry 3

Ciaffoni Joseph · CIK 0001443841 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 459,823

F3 · shares: Shares withheld by the issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.

Read SEC document
February 10, 2023 Filed Feb 14, 2023 22:16 UTC
Ciaffoni JosephDirector · President and CEO
GrantCommon Stock 137,694 Not disclosed Not disclosed
Disclosure

SEC source: 0001062993-23-003475 · form4.xml · nonDerivative · entry 2

Ciaffoni Joseph · CIK 0001443841 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 503,944

F2 · price: Effective February 10, 2023, the Compensation Committee of the Board of Directors of the issuer determined that performance-vesting criteria were met with regard to an aggregate of 137,694 performance share units granted in the issuer's three prior fiscal years.

Read SEC document
February 10, 2023 Filed Feb 14, 2023 22:16 UTC
Ciaffoni JosephDirector · President and CEO
GrantCommon Stock 117,500 $0.00 $0.00
Disclosure

SEC source: 0001062993-23-003475 · form4.xml · nonDerivative · entry 1

Ciaffoni Joseph · CIK 0001443841 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 366,250

F1 · shares: Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2024, and the balance of the restricted stock units vest in equal annual installments over the following three-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock.

Read SEC document
February 10, 2023 Filed Feb 14, 2023 22:19 UTC
Smith Thomas BEVP and Chief Medical Officer
GrantCommon Stock 31,185 $0.00 $0.00
Disclosure

SEC source: 0001062993-23-003481 · form4.xml · nonDerivative · entry 1

Smith Thomas B · CIK 0001748462 · EVP and Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,185

F1 · shares: Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2024, and the balance of the restricted stock units vest in equal annual installments over the following three-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock.

Read SEC document
February 10, 2023 Filed Feb 14, 2023 22:15 UTC
Dreyer ScottEVP & Chief Commercial Officer
Tax withholdingCommon Stock 6,797 $26.75 $181,819.75
Disclosure

SEC source: 0001062993-23-003474 · form4.xml · nonDerivative · entry 4

Dreyer Scott · CIK 0001746251 · EVP & Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 148,206

F4 · shares: Shares withheld by the issuer to satisfy applicable withholding taxes upon vesting of performance stock units.

Read SEC document
February 10, 2023 Filed Feb 14, 2023 22:15 UTC
Dreyer ScottEVP & Chief Commercial Officer
Tax withholdingCommon Stock 14,529 $26.75 $388,650.75
Disclosure

SEC source: 0001062993-23-003474 · form4.xml · nonDerivative · entry 3

Dreyer Scott · CIK 0001746251 · EVP & Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 155,003

F3 · shares: Shares withheld by the issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.

Read SEC document
February 10, 2023 Filed Feb 14, 2023 22:15 UTC
Dreyer ScottEVP & Chief Commercial Officer
GrantCommon Stock 22,459 Not disclosed Not disclosed
Disclosure

SEC source: 0001062993-23-003474 · form4.xml · nonDerivative · entry 2

Dreyer Scott · CIK 0001746251 · EVP & Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 169,532

F2 · price: Effective February 10, 2023, the Compensation Committee of the Board of Directors of the issuer determined that performance-vesting criteria were met with regard to an aggregate of 22,459 performance share units granted in the issuer's three prior fiscal years.

Read SEC document
February 10, 2023 Filed Feb 14, 2023 22:15 UTC
Dreyer ScottEVP & Chief Commercial Officer
GrantCommon Stock 44,275 $0.00 $0.00
Disclosure

SEC source: 0001062993-23-003474 · form4.xml · nonDerivative · entry 1

Dreyer Scott · CIK 0001746251 · EVP & Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 147,073

F1 · shares: Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2024, and the balance of the restricted stock units vest in equal annual installments over the following three-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock.

Read SEC document
January 09, 2023 Filed Jan 11, 2023 21:06 UTC
Dreyer ScottEVP & Chief Commercial Officer
SaleCommon Stock 69 $28.58 $1,972.02
Disclosure

SEC source: 0001062993-23-000826 · form4.xml · nonDerivative · entry 3

Dreyer Scott · CIK 0001746251 · EVP & Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 102,798

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 1, 2022.

Read SEC document
January 09, 2023 Filed Jan 11, 2023 21:06 UTC
Dreyer ScottEVP & Chief Commercial Officer
SaleCommon Stock 7,341 $27.83 $204,300.03
Disclosure

SEC source: 0001062993-23-000826 · form4.xml · nonDerivative · entry 2

Dreyer Scott · CIK 0001746251 · EVP & Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 102,867

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 1, 2022.

F3 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.49 to $28.35, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3).

Read SEC document
January 09, 2023 Filed Jan 11, 2023 21:06 UTC
Dreyer ScottEVP & Chief Commercial Officer
SaleCommon Stock 10,424 $27.08 $282,281.92
Disclosure

SEC source: 0001062993-23-000826 · form4.xml · nonDerivative · entry 1

Dreyer Scott · CIK 0001746251 · EVP & Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 110,208

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 1, 2022.

F2 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.49 to $27.48, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2).

Read SEC document
December 27, 2022 Filed Dec 28, 2022 00:17 UTC Exercise / conversionStock Option (Right to Purchase) · Derivative 3,820 $0.00 Strike: $16.15 $0.00
Disclosure

SEC source: 0001062993-22-024501 · form4.xml · derivative · entry 12

Heffernan Michael Thomas · CIK 0001448914 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,820 shares

Expires 2026-01-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The option, initially representing a right to purchase a total of 109,005 shares, is fully vested and exercisable.

Read SEC document
December 27, 2022 Filed Dec 28, 2022 00:17 UTC Exercise / conversionStock Option (Right to Purchase) · Derivative 15,995 $0.00 Strike: $16.15 $0.00
Disclosure

SEC source: 0001062993-22-024501 · form4.xml · derivative · entry 11

Heffernan Michael Thomas · CIK 0001448914 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,820

Underlying: Common Stock · 15,995 shares

Expires 2026-01-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The option, initially representing a right to purchase a total of 109,005 shares, is fully vested and exercisable.

Read SEC document
December 27, 2022 Filed Dec 28, 2022 00:17 UTC SaleCommon Stock 3,820 $24.16 $92,291.20
Disclosure

SEC source: 0001062993-22-024501 · form4.xml · nonDerivative · entry 8

Heffernan Michael Thomas · CIK 0001448914 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,023

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2022.

F4 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.00 to $24.25, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4).

Read SEC document
December 27, 2022 Filed Dec 28, 2022 00:17 UTC Exercise / conversionCommon Stock 3,820 $16.15 $61,693.00
Disclosure

SEC source: 0001062993-22-024501 · form4.xml · nonDerivative · entry 7

Heffernan Michael Thomas · CIK 0001448914 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,843

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 27, 2022 Filed Dec 28, 2022 00:17 UTC SaleCommon Stock 15,995 $23.63 $377,961.85
Disclosure

SEC source: 0001062993-22-024501 · form4.xml · nonDerivative · entry 6

Heffernan Michael Thomas · CIK 0001448914 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,023

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2022.

F3 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.00 to $23.99, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3).

Read SEC document
December 27, 2022 Filed Dec 28, 2022 00:17 UTC Exercise / conversionCommon Stock 15,995 $16.15 $258,319.25
Disclosure

SEC source: 0001062993-22-024501 · form4.xml · nonDerivative · entry 5

Heffernan Michael Thomas · CIK 0001448914 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,018

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 27, 2022 Filed Dec 28, 2022 00:16 UTC
Ciaffoni JosephDirector · President and CEO
SaleCommon Stock 400 $24.19 $9,676.00
Disclosure

SEC source: 0001062993-22-024500 · form4.xml · nonDerivative · entry 4

Ciaffoni Joseph · CIK 0001443841 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 248,750

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 25, 2022.

F4 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.14 to $24.23, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4).

Read SEC document
December 27, 2022 Filed Dec 28, 2022 00:16 UTC
Ciaffoni JosephDirector · President and CEO
SaleCommon Stock 1,804 $23.65 $42,664.60
Disclosure

SEC source: 0001062993-22-024500 · form4.xml · nonDerivative · entry 3

Ciaffoni Joseph · CIK 0001443841 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 249,150

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 25, 2022.

F3 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.00 to $23.99, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3).

Read SEC document
December 23, 2022 Filed Dec 28, 2022 00:17 UTC Exercise / conversionStock Option (Right to Purchase) · Derivative 4,989 $0.00 Strike: $16.15 $0.00
Disclosure

SEC source: 0001062993-22-024501 · form4.xml · derivative · entry 10

Heffernan Michael Thomas · CIK 0001448914 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,815

Underlying: Common Stock · 4,989 shares

Expires 2026-01-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The option, initially representing a right to purchase a total of 109,005 shares, is fully vested and exercisable.

Read SEC document
December 23, 2022 Filed Dec 28, 2022 00:17 UTC SaleCommon Stock 4,989 $23.00 $114,747.00
Disclosure

SEC source: 0001062993-22-024501 · form4.xml · nonDerivative · entry 4

Heffernan Michael Thomas · CIK 0001448914 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,023

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2022.

F2 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.00 to $23.03, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2).

Read SEC document
December 23, 2022 Filed Dec 28, 2022 00:17 UTC Exercise / conversionCommon Stock 4,989 $16.15 $80,572.35
Disclosure

SEC source: 0001062993-22-024501 · form4.xml · nonDerivative · entry 3

Heffernan Michael Thomas · CIK 0001448914 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,012

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 23, 2022 Filed Dec 28, 2022 00:16 UTC
Ciaffoni JosephDirector · President and CEO
SaleCommon Stock 147 $23.00 $3,381.00
Disclosure

SEC source: 0001062993-22-024500 · form4.xml · nonDerivative · entry 2

Ciaffoni Joseph · CIK 0001443841 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 250,954

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 25, 2022.

F2 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.00 to $23.03, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2).

Read SEC document
December 22, 2022 Filed Dec 28, 2022 00:17 UTC Exercise / conversionStock Option (Right to Purchase) · Derivative 237 $0.00 Strike: $16.15 $0.00
Disclosure

SEC source: 0001062993-22-024501 · form4.xml · derivative · entry 9

Heffernan Michael Thomas · CIK 0001448914 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,804

Underlying: Common Stock · 237 shares

Expires 2026-01-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The option, initially representing a right to purchase a total of 109,005 shares, is fully vested and exercisable.

Read SEC document
December 22, 2022 Filed Dec 28, 2022 00:17 UTC SaleCommon Stock 237 $23.00 $5,451.00
Disclosure

SEC source: 0001062993-22-024501 · form4.xml · nonDerivative · entry 2

Heffernan Michael Thomas · CIK 0001448914 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,023

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2022.

Read SEC document
December 22, 2022 Filed Dec 28, 2022 00:17 UTC Exercise / conversionCommon Stock 237 $16.15 $3,827.55
Disclosure

SEC source: 0001062993-22-024501 · form4.xml · nonDerivative · entry 1

Heffernan Michael Thomas · CIK 0001448914 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,260

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 22, 2022 Filed Dec 28, 2022 00:16 UTC
Ciaffoni JosephDirector · President and CEO
SaleCommon Stock 110 $23.00 $2,530.00
Disclosure

SEC source: 0001062993-22-024500 · form4.xml · nonDerivative · entry 1

Ciaffoni Joseph · CIK 0001443841 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 251,101

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 25, 2022.

Read SEC document
December 21, 2022 Filed Dec 22, 2022 00:28 UTC
Ciaffoni JosephDirector · President and CEO
SaleCommon Stock 7,333 $23.11 $169,465.63
Disclosure

SEC source: 0001062993-22-024355 · form4.xml · nonDerivative · entry 3

Ciaffoni Joseph · CIK 0001443841 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 251,211

F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 25, 2022.

F4 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.00 to $23.40, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4).

Read SEC document
December 21, 2022 Filed Dec 22, 2022 00:28 UTC Exercise / conversionStock Option (Right to Purchase) · Derivative 46,600 $0.00 Strike: $16.15 $0.00
Disclosure

SEC source: 0001062993-22-024356 · form4.xml · derivative · entry 9

Heffernan Michael Thomas · CIK 0001448914 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,041

Underlying: Common Stock · 46,600 shares

Expires 2026-01-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The option, initially representing a right to purchase a total of 109,005 shares, is fully vested and exercisable.

Read SEC document
December 21, 2022 Filed Dec 22, 2022 00:28 UTC SaleCommon Stock 46,600 $23.11 $1,076,926.00
Disclosure

SEC source: 0001062993-22-024356 · form4.xml · nonDerivative · entry 6

Heffernan Michael Thomas · CIK 0001448914 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,023

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2022.

F4 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.00 to $23.40, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4).

Read SEC document
December 21, 2022 Filed Dec 22, 2022 00:28 UTC Exercise / conversionCommon Stock 46,600 $16.15 $752,590.00
Disclosure

SEC source: 0001062993-22-024356 · form4.xml · nonDerivative · entry 5

Heffernan Michael Thomas · CIK 0001448914 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 74,623

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 20, 2022 Filed Dec 22, 2022 00:28 UTC
Ciaffoni JosephDirector · President and CEO
SaleCommon Stock 9,375 $23.07 $216,281.25
Disclosure

SEC source: 0001062993-22-024355 · form4.xml · nonDerivative · entry 2

Ciaffoni Joseph · CIK 0001443841 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 258,544

F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 25, 2022.

F3 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.00 to $23.33, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3).

Read SEC document
December 20, 2022 Filed Dec 22, 2022 00:28 UTC Exercise / conversionStock Option (Right to Purchase) · Derivative 33,758 $0.00 Strike: $16.15 $0.00
Disclosure

SEC source: 0001062993-22-024356 · form4.xml · derivative · entry 8

Heffernan Michael Thomas · CIK 0001448914 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 71,641

Underlying: Common Stock · 33,758 shares

Expires 2026-01-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The option, initially representing a right to purchase a total of 109,005 shares, is fully vested and exercisable.

Read SEC document
December 20, 2022 Filed Dec 22, 2022 00:28 UTC SaleCommon Stock 33,758 $23.08 $779,134.64
Disclosure

SEC source: 0001062993-22-024356 · form4.xml · nonDerivative · entry 4

Heffernan Michael Thomas · CIK 0001448914 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,023

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2022.

F3 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.00 to $23.33, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3).

Read SEC document
December 20, 2022 Filed Dec 22, 2022 00:28 UTC Exercise / conversionCommon Stock 33,758 $16.15 $545,191.70
Disclosure

SEC source: 0001062993-22-024356 · form4.xml · nonDerivative · entry 3

Heffernan Michael Thomas · CIK 0001448914 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,781

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 19, 2022 Filed Dec 22, 2022 00:28 UTC
Ciaffoni JosephDirector · President and CEO
SaleCommon Stock 1,134 $23.01 $26,093.34
Disclosure

SEC source: 0001062993-22-024355 · form4.xml · nonDerivative · entry 1

Ciaffoni Joseph · CIK 0001443841 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 267,919

F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 25, 2022.

F2 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.00 to $23.03, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2).

Read SEC document
December 19, 2022 Filed Dec 22, 2022 00:28 UTC Exercise / conversionStock Option (Right to Purchase) · Derivative 3,606 $0.00 Strike: $16.15 $0.00
Disclosure

SEC source: 0001062993-22-024356 · form4.xml · derivative · entry 7

Heffernan Michael Thomas · CIK 0001448914 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 105,399

Underlying: Common Stock · 3,606 shares

Expires 2026-01-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The option, initially representing a right to purchase a total of 109,005 shares, is fully vested and exercisable.

Read SEC document
December 19, 2022 Filed Dec 22, 2022 00:28 UTC SaleCommon Stock 3,606 $23.04 $83,082.24
Disclosure

SEC source: 0001062993-22-024356 · form4.xml · nonDerivative · entry 2

Heffernan Michael Thomas · CIK 0001448914 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,023

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2022.

F2 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.00 to $23.11, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2).

Read SEC document
December 19, 2022 Filed Dec 22, 2022 00:28 UTC Exercise / conversionCommon Stock 3,606 $16.15 $58,236.90
Disclosure

SEC source: 0001062993-22-024356 · form4.xml · nonDerivative · entry 1

Heffernan Michael Thomas · CIK 0001448914 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,629

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.